Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPCX
SpaceX
SPCX
|
+$1.27B |
| 2 |
SNDK
Sandisk
SNDK
|
+$674M |
| 3 |
Credo Technology Group
CRDO
|
+$476M |
| 4 |
NBIS
Nebius Group N.V.
NBIS
|
+$452M |
| 5 |
Vertiv
VRT
|
+$420M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.98B |
| 2 |
Amazon
AMZN
|
+$1.25B |
| 3 |
Shopify
SHOP
|
+$1.08B |
| 4 |
Edwards Lifesciences
EW
|
+$1.07B |
| 5 |
Microsoft
MSFT
|
+$630M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 43.11% |
| 2 | Communication Services | 13.94% |
| 3 | Consumer Discretionary | 10.64% |
| 4 | Industrials | 9.08% |
| 5 | Healthcare | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Devon Energy
DVN
$52.1B
| $12.6M | 0.01% |
303,853
+98,468
| +48% | +$4.56M |
|
377
Cognex
CGNX
$10.2B
| $12.5M | 0.01% |
+172,767
| New | +$10.5M |
|
378
Teva Pharmaceuticals
TEVA
$42.5B
| $12.2M | 0.01% |
359,114
-1,080,037
| -75% | -$36M |
|
379
Bunge Global
BG
$22.2B
| $12M | 0.01% |
112,738
+39
| +0% | +$4.79K |
|
380
HubSpot
HUBS
$13B
| $11.8M | 0.01% |
+64,793
| New | +$13.5M |
|
|
TTAN
381
ServiceTitan Inc
TTAN
$9.53B
| $11.8M | 0.01% |
166,818
-213,650
| -56% | -$13.8M |
|
382
Utz Brands
UTZ
$1.26B
| $11.7M | 0.01% |
1,521,159
+128,026
| +9% | +$955K |
|
|
PCG.PRX
383
PG&E Corp 6.000% Series A Preferred Stock
PCG.PRX
$1.31B
| $11.5M | 0.01% |
279,165
| – | – |
|
384
Cushman & Wakefield Ltd
CWK
$3.31B
| $11.2M | 0.01% |
836,686
+292,462
| +54% | +$3.92M |
|
385
PENN Entertainment
PENN
$2.33B
| $11M | 0.01% |
516,715
-176,457
| -25% | -$3.16M |
|
386
ESCO Technologies
ESE
$7.18B
| $10.9M | 0.01% |
+31,201
| New | +$9.76M |
|
387
Equinor
EQNR
$98.2B
| $10.9M | 0.01% |
346,819
+143,452
| +71% | +$5.36M |
|
388
Skyward Specialty Insurance
SKWD
$2.36B
| $10.7M | 0.01% |
183,657
-238,596
| -57% | -$11.3M |
|
389
Mineralys Therapeutics
MLYS
$2.26B
| $10.3M | 0.01% |
382,747
-883,427
| -70% | -$24.2M |
|
390
Repligen
RGEN
$9.95B
| $10.2M | 0.01% |
74,996
-46,243
| -38% | -$5.68M |
|
391
Korn Ferry
KFY
$4.43B
| $10.2M | 0.01% |
153,286
-494,590
| -76% | -$33.5M |
|
|
VG
392
Venture Global Inc
VG
$35.5B
| $10M | 0.01% |
900,136
-17,373
| -2% | -$220K |
|
393
Ormat Technologies
ORA
$6.34B
| $10M | 0.01% |
91,938
+1,610
| +2% | +$200K |
|
|
MIAX
394
Miami International Holdings
MIAX
$4.27B
| $9.93M | 0.01% |
+267,303
| New | +$12M |
|
395
Republic Services
RSG
$68B
| $9.91M | 0.01% |
46,501
| – | – |
|
396
Concrete Pumping Holdings
BBCP
$464M
| $9.61M | 0.01% |
797,410
-683,519
| -46% | -$5.86M |
|
|
XZO
397
Exzeo Group
XZO
$1.52B
| $9.59M | 0.01% |
568,680
-6,237
| -1% | -$91.7K |
|
398
Nextpower Inc. Common Stock
NXT
$13B
| $9.46M | 0.01% |
79,385
-710
| -0.9% | -$87.6K |
|
399
Fastenal
FAST
$57.1B
| $9.44M | 0.01% |
+196,625
| New | +$8.92M |
|
400
Prestige Consumer Healthcare
PBH
$2.49B
| $9.39M | 0.01% |
198,715
-8,381
| -4% | -$431K |
|
Similar funds
Jennison Associates's Q2 2026 Portfolio in Review
As of Q2 2026, Jennison Associates held 641 positions worth $167B, up 15% from $145B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Jennison Associates withdrew a net $6.22B in Q2 2026, closing 74 positions and reducing 282 holdings. Its most notable exit was Gilead Sciences, an estimated $176M position sold in full.
By sector, the portfolio is most concentrated in Technology at 43% of assets, up from 39% a quarter earlier, followed by Communication Services and Consumer Discretionary.
Against the trend, Jennison Associates opened a new position in SpaceX worth $1.27B.
- Jennison Associates's largest Q2 2026 buy was SpaceX: 7,448,891 shares worth $1.27B.
- Jennison Associates added most to Credo Technology Group in Q2 2026, an estimated $476M increase.
- Jennison Associates's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $1.98B.
- Jennison Associates fully exited Gilead Sciences in Q2 2026, selling an estimated $176M.
- Jennison Associates's ten largest holdings make up 45% of its $167B portfolio in Q2 2026.
- Jennison Associates opened 79 new positions and closed 74 in Q2 2026.
- Jennison Associates's portfolio value rose 15% quarter-over-quarter to $167B.
Based on Jennison Associates's 13F filing for Q2 2026, filed 3 Aug 2026.